< Back to all Breaking News
SPHS
10/2/2017 08:10am
Sophiris Bio provides enrollment update on topsalysin Phase 2b study
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.